Leveraging Social Networks to Increase COVID-19 Testing Uptake
NCT04873401
COVID-19, Chemically-Induced Disorders
New York, United States
View Trial DetailsNCT Number: NCT01300806
The goal of this research is to assess the impact of the "screening, brief intervention, and referral to treatment" (SBIRT) intervention strategy for harmful substance use among HIV-positive people.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
The specific aims of the study are:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Inability to answer questions with interviewer assistance. Not receiving primary care in clinic.
Time frame: 6 months
Time frame: 6 months
University of California, San Francisco
Other
Acronym: SBIRT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04873401
COVID-19, Chemically-Induced Disorders
New York, United States
View Trial DetailsNCT05378399
Adherence, Medication, Adherence, Treatment
Boston, Massachusetts, United States
View Trial DetailsNCT05286879
Behavior, Chemically-Induced Disorders
New Haven, Connecticut, United States
View Trial DetailsNCT06008990
Buprenorphine Dependence, Chemically-Induced Disorders
Indianapolis, Indiana, United States
View Trial Details